BrainChild Bio develops CAR-T cell therapies for pediatric brain tumors, focusing on DIPG.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BrainChild Bio — Funding & Investors." VCBacked, January 21, 2025, https://www.vcbacked.co/company/brainchild-bio. Accessed July 3, 2026.
VCBacked. (2025). BrainChild Bio — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/brainchild-bio
{{cite web |title=BrainChild Bio — Funding & Investors |url=https://www.vcbacked.co/company/brainchild-bio |website=VCBacked |access-date=July 3, 2026}}Profile data sourced and verified per the VCBacked methodology. Last funding round dated .